Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Buy
56
NEOG Quote, Financials, Valuation and Earnings
Last price:
$9.25
Seasonality move
:
-2.9%
Day range:
$9.19 - $9.59
52-week range:
$3.87 - $12.07
Dividend yield:
0%
P/E ratio:
2,124.15x
P/S ratio:
2.28x
P/B ratio:
0.96x
Volume:
2M
Avg. volume:
4.3M
1-year change:
-20.26%
Market cap:
$2B
Revenue:
$894.7M
EPS (TTM):
-$2.78
| Period Ending | 2021-05-31 | 2022-05-31 | 2023-05-31 | 2024-05-31 | 2025-05-31 | |
|---|---|---|---|---|---|---|
| Revenue | $468.5M | $527.2M | $822.4M | $924.2M | $894.7M | |
| Revenue Growth (YoY) | 12.03% | 12.53% | 56.02% | 12.38% | -3.2% | |
| Cost of Revenues | $253.4M | $284.1M | $416.5M | $461.6M | $473.3M | |
| Gross Profit | $215.1M | $243M | $406M | $462.6M | $421.4M | |
| Gross Profit Margin | 45.91% | 46.1% | 49.36% | 50.06% | 47.1% | |
| R&D Expenses | $16.2M | $17M | $26M | $22.5M | $21.1M | |
| Selling, General & Admin | $124.6M | $167.3M | $342.4M | $382.8M | $402M | |
| Other Inc / (Exp) | -$515K | $322K | -$6.8M | -$5.9M | -$3.6M | |
| Operating Expenses | $140.9M | $184.4M | $368.4M | $385.2M | $412M | |
| Operating Income | $74.2M | $58.6M | $37.5M | $77.4M | $9.4M | |
| Net Interest Expenses | -- | -- | $56M | $75.7M | $69.7M | |
| EBT. Incl. Unusual Items | $75.3M | $60.2M | -$22M | -$14.3M | -$1.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $14.4M | $11.9M | $828K | -$4.9M | -$41.1M | |
| Net Income to Company | $60.9M | $48.3M | -$22.9M | -$9.4M | -$1.1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $60.9M | $48.3M | -$22.9M | -$9.4M | -$1.1B | |
| Basic EPS (Cont. Ops) | $0.57 | $0.45 | -$0.12 | -$0.04 | -$5.03 | |
| Diluted EPS (Cont. Ops) | $0.57 | $0.45 | -$0.12 | -$0.04 | -$5.03 | |
| Weighted Average Basic Share | $106.5M | $107.7M | $188.9M | $216.5M | $216.9M | |
| Weighted Average Diluted Share | $107.1M | $108M | $188.9M | $216.5M | $216.9M | |
| EBITDA | $95.2M | $82.3M | $125.9M | $198.7M | $135.1M | |
| EBIT | $74.2M | $58.6M | $37.5M | $77.4M | $9.4M | |
| Revenue (Reported) | $468.5M | $527.2M | $822.4M | $924.2M | $894.7M | |
| Operating Income (Reported) | $74.2M | $58.6M | $37.5M | $77.4M | $9.4M | |
| Operating Income (Adjusted) | $74.2M | $58.6M | $37.5M | $77.4M | $9.4M | |
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Revenue | $130.5M | $230M | $229.6M | $231.3M | $224.7M | |
| Revenue Growth (YoY) | 13.49% | 76.25% | -0.18% | 0.71% | -2.84% | |
| Cost of Revenues | $69.9M | $117.5M | $112.9M | $141.5M | $140.9M | |
| Gross Profit | $60.6M | $112.5M | $116.8M | $89.7M | $83.8M | |
| Gross Profit Margin | 46.43% | 48.92% | 50.85% | 38.8% | 37.29% | |
| R&D Expenses | $4.3M | $6.8M | $5.8M | $5.1M | $4.6M | |
| Selling, General & Admin | $43.8M | $113.3M | $96.6M | $104.3M | $107.5M | |
| Other Inc / (Exp) | $235K | -$6.4M | -$2M | -$463.1M | -- | |
| Operating Expenses | $48.1M | $120.2M | $95.9M | $72.7M | $83M | |
| Operating Income | $12.5M | -$7.7M | $20.9M | $17.1M | $748K | |
| Net Interest Expenses | -- | $20.5M | $18.6M | $18.1M | $14.8M | |
| EBT. Incl. Unusual Items | $12.9M | -$34.1M | -$3.7M | -$476.6M | -$20.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.1M | $7.8M | -$260K | -$20.3M | -$4.4M | |
| Net Income to Company | $10.8M | -$41.8M | -$3.5M | -$456.3M | -$15.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $10.8M | -$41.8M | -$3.5M | -$456.3M | -$15.9M | |
| Basic EPS (Cont. Ops) | $0.10 | -$0.19 | -$0.02 | -$2.10 | -$0.07 | |
| Diluted EPS (Cont. Ops) | $0.10 | -$0.19 | -$0.02 | -$2.10 | -$0.07 | |
| Weighted Average Basic Share | $107.6M | $216.1M | $216.4M | $216.8M | $217.4M | |
| Weighted Average Diluted Share | $108.1M | $216.1M | $216.4M | $216.8M | $217.4M | |
| EBITDA | $18.3M | $19.1M | $50.4M | $47.1M | $29.7M | |
| EBIT | $12.5M | -$7.7M | $20.9M | $17.1M | $748K | |
| Revenue (Reported) | $130.5M | $230M | $229.6M | $231.3M | $224.7M | |
| Operating Income (Reported) | $12.5M | -$7.7M | $20.9M | $17.1M | $748K | |
| Operating Income (Adjusted) | $12.5M | -$7.7M | $20.9M | $17.1M | $748K | |
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Revenue | $503M | $630.7M | $918.7M | $913.8M | $880.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $270.8M | $333.5M | $454M | $508.6M | $568.3M | |
| Gross Profit | $232.1M | $297.2M | $464.7M | $405.3M | $312.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $17M | $20.1M | $26.8M | $20.3M | $20.5M | |
| Selling, General & Admin | $144.9M | $254.3M | $365.2M | $397.1M | $413.6M | |
| Other Inc / (Exp) | -$229K | -$6.5M | -$2.8M | -$466.4M | -- | |
| Operating Expenses | $161.9M | $274.4M | $385.5M | $350.3M | $323.3M | |
| Operating Income | $70.2M | $22.8M | $79.2M | $55M | -$11.2M | |
| Net Interest Expenses | -- | $20.5M | $72.5M | $74.8M | $66.2M | |
| EBT. Incl. Unusual Items | $70.8M | -$1.9M | $3.3M | -$504.4M | -$617.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $13.7M | $14.4M | -$8.5M | -$28.1M | -$14.7M | |
| Net Income to Company | $57M | -$16.2M | $11.8M | -$476.3M | -$602.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $57M | -$16.2M | $11.8M | -$476.3M | -$602.7M | |
| Basic EPS (Cont. Ops) | $0.53 | $0.04 | $0.05 | -$2.20 | -$2.78 | |
| Diluted EPS (Cont. Ops) | $0.53 | $0.04 | $0.05 | -$2.20 | -$2.78 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $93.2M | $67.5M | $193.3M | $173.4M | $106.4M | |
| EBIT | $70.2M | $22.8M | $79.2M | $55M | -$11.2M | |
| Revenue (Reported) | $503M | $630.7M | $918.7M | $913.8M | $880.3M | |
| Operating Income (Reported) | $70.2M | $22.8M | $79.2M | $55M | -$11.2M | |
| Operating Income (Adjusted) | $70.2M | $22.8M | $79.2M | $55M | -$11.2M | |
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Revenue | $258.8M | $362.4M | $458.6M | $448.2M | $433.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $138.2M | $187.6M | $225.1M | $272.1M | $278.1M | |
| Gross Profit | $120.6M | $174.8M | $233.5M | $176.2M | $155.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $8.7M | $11.7M | $12.5M | $10.3M | $9.7M | |
| Selling, General & Admin | $77.7M | $164.7M | $187.5M | $201.8M | $213.4M | |
| Other Inc / (Exp) | $14K | -$6.8M | -$2.8M | -$463.4M | -- | |
| Operating Expenses | $86.4M | $176.4M | $193.5M | $150.4M | $171.1M | |
| Operating Income | $34.2M | -$1.6M | $40M | $25.7M | -$15.3M | |
| Net Interest Expenses | -- | $20.5M | $37.1M | $36.8M | $31.3M | |
| EBT. Incl. Unusual Items | $34.7M | -$27.4M | -$2.1M | -$492.2M | $23.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.8M | $9.2M | -$100K | -$23.3M | $3M | |
| Net Income to Company | $27.9M | -$36.6M | -$2M | -$468.9M | $20.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $27.9M | -$36.6M | -$2M | -$468.9M | $20.4M | |
| Basic EPS (Cont. Ops) | $0.26 | -$0.15 | -$0.01 | -$2.16 | $0.09 | |
| Diluted EPS (Cont. Ops) | $0.26 | -$0.15 | -$0.01 | -$2.16 | $0.09 | |
| Weighted Average Basic Share | $215.1M | $324M | $432.7M | $433.5M | $434.6M | |
| Weighted Average Diluted Share | $216.2M | $324M | $433.3M | $433.5M | $434.7M | |
| EBITDA | $45.7M | $30.9M | $98.2M | $85.6M | $42.6M | |
| EBIT | $34.2M | -$1.6M | $40M | $25.7M | -$15.3M | |
| Revenue (Reported) | $258.8M | $362.4M | $458.6M | $448.2M | $433.9M | |
| Operating Income (Reported) | $34.2M | -$1.6M | $40M | $25.7M | -$15.3M | |
| Operating Income (Adjusted) | $34.2M | -$1.6M | $40M | $25.7M | -$15.3M | |
| Period Ending | 2021-05-31 | 2022-05-31 | 2023-05-31 | 2024-05-31 | 2025-05-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $381.1M | $381.1M | $245.6M | $170.9M | $129M | |
| Short Term Investments | $305.5M | $336.6M | $82.3M | $325K | -- | |
| Accounts Receivable, Net | $91.8M | $99.7M | $153.3M | $173M | $153.4M | |
| Inventory | $100.7M | $122.3M | $133.8M | $189.3M | $190.9M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $17.8M | $23.8M | $53.3M | $56M | $53.3M | |
| Total Current Assets | $591.5M | $626.8M | $585.9M | $589.2M | $576.9M | |
| Property Plant And Equipment | $102.9M | $113.8M | $210.7M | $291.9M | $356.3M | |
| Long-Term Investments | -- | -- | -- | $229K | -- | |
| Goodwill | $131.5M | $142.7M | $2.1B | $2.1B | $1.1B | |
| Other Intangibles | $92.3M | $107.5M | $1.6B | $1.5B | $1.4B | |
| Other Long-Term Assets | $2M | $2.2M | $15.2M | $20.4M | $35.2M | |
| Total Assets | $924.1M | $999.9M | $4.6B | $4.6B | $3.5B | |
| Accounts Payable | $23.9M | $34.6M | $76.7M | $83.1M | $79.6M | |
| Accrued Expenses | $13.2M | $24.5M | $11.1M | $11M | $11.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $2.4M | -- | |
| Other Current Liabilities | -- | -- | $20.9M | $22.8M | $38.7M | |
| Total Current Liabilities | $53.6M | $77.8M | $145.5M | $154.3M | $174M | |
| Long-Term Debt | $1.2K | $1.8K | $894.3M | $898.7M | $887.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $83.7M | $112.5M | $1.4B | $1.4B | $1.4B | |
| Common Stock | $17.2M | $17.2M | $34.6M | $34.7M | $34.7M | |
| Other Common Equity Adj | -$11.4M | -$27.8M | -$33.3M | -$30M | -$28.9M | |
| Common Equity | $840.4M | $887.4M | $3.1B | $3.1B | $2.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $840.4M | $887.4M | $3.1B | $3.1B | $2.1B | |
| Total Liabilities and Equity | $924.1M | $999.9M | $4.6B | $4.6B | $3.5B | |
| Cash and Short Terms | $381.1M | $381.1M | $245.6M | $170.9M | $129M | |
| Total Debt | $1.2K | $1.8K | $894.3M | $901.1M | $907M | |
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $389.2M | $276.3M | $230.3M | $140.2M | $145.3M | |
| Short Term Investments | $338.1M | $176.3M | $24.5M | -- | -- | |
| Accounts Receivable, Net | $92.5M | $142.7M | $150.5M | $164.1M | $132M | |
| Inventory | $107.1M | $136.1M | $160.5M | $198.3M | $162.8M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $22.4M | $88.2M | $83.1M | $67.9M | -- | |
| Total Current Assets | $611.2M | $643.3M | $624.4M | $570.4M | $574.6M | |
| Property Plant And Equipment | $103M | $151.9M | $259.3M | $327.8M | $347.5M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $142.6M | $2.1B | $2.1B | $1.7B | -- | |
| Other Intangibles | $109.1M | $1.6B | $1.6B | $1.5B | -- | |
| Other Long-Term Assets | $2M | $3.9M | $16M | $20.2M | -- | |
| Total Assets | $967.9M | $4.6B | $4.6B | $4.1B | $3.4B | |
| Accounts Payable | $34.2M | $79.3M | $112.2M | $79.6M | $63M | |
| Accrued Expenses | $18.8M | $44.2M | $31.3M | $11.1M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | $2.6M | $2.6M | -- | |
| Other Current Liabilities | -- | -- | -- | $24.6M | -- | |
| Total Current Liabilities | $62.7M | $152.6M | $176.6M | $151.2M | $147.1M | |
| Long-Term Debt | -- | $924M | $886.9M | $889.9M | $792.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $102.5M | $1.5B | $1.5B | $1.4B | $1.3B | |
| Common Stock | $17.2M | $34.6M | $34.6M | $34.7M | $34.8M | |
| Other Common Equity Adj | -$24.2M | -$40.5M | -$25.1M | -$44.7M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $865.5M | $3.1B | $3.1B | $2.7B | $2.1B | |
| Total Liabilities and Equity | $967.9M | $4.6B | $4.6B | $4.1B | $3.4B | |
| Cash and Short Terms | $389.2M | $276.3M | $230.3M | $140.2M | $145.3M | |
| Total Debt | -- | $924M | $889.5M | $892.4M | $792.9M | |
| Period Ending | 2021-05-31 | 2022-05-31 | 2023-05-31 | 2024-05-31 | 2025-05-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $60.9M | $48.3M | -$22.9M | -$9.4M | -$1.1B | |
| Depreciation & Amoritzation | $21M | $23.7M | $88.4M | $121.2M | $125.7M | |
| Stock-Based Compensation | $6.4M | $7.2M | $10.2M | $13.8M | $17.3M | |
| Change in Accounts Receivable | -$2.6M | -$7.8M | -$53.9M | -$20.1M | $11.6M | |
| Change in Inventories | $2.5M | -$21.1M | $10M | -$55.9M | -$16.1M | |
| Cash From Operations | $81.1M | $68M | $41M | $34.7M | $56.2M | |
| Capital Expenditures | $26.7M | $24.4M | $65.8M | $111.4M | $104.6M | |
| Cash Acquisitions | $50.8M | $38.7M | -$11.7M | -- | -- | |
| Cash From Investing | -$105.6M | -$97.2M | $201M | -$29.3M | -$99.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $550M | |
| Long-Term Debt Repaid | -- | -- | -$100M | -$420K | -$550.3M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.1M | -$1.1M | -$19.3M | -$118K | -$3.5M | |
| Cash From Financing | $33.5M | $6.8M | -$118.1M | $2.5M | $421K | |
| Beginning Cash (CF) | $75.6M | $44.5M | $163.2M | $170.6M | $129M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9.3M | -$31.1M | $118.8M | $7.4M | -$41.6M | |
| Ending Cash (CF) | $85.2M | $4.6M | $276.8M | $177.5M | $88.3M | |
| Levered Free Cash Flow | $54.4M | $43.6M | -$24.7M | -$76.7M | -$48.4M | |
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $10.8M | -$41.8M | -$3.5M | -$456.3M | -$15.9M | |
| Depreciation & Amoritzation | $5.8M | $26.7M | $29.5M | $30M | $28.9M | |
| Stock-Based Compensation | $1.7M | $2.6M | $3.5M | $4.8M | $4.3M | |
| Change in Accounts Receivable | -$5.5M | -$49.3M | -$12.6M | $536K | -$6.3M | |
| Change in Inventories | -$5.1M | $14.8M | -$19.6M | -$7.5M | $18.7M | |
| Cash From Operations | $17.8M | -$18.7M | $15.3M | $40.3M | $19.4M | |
| Capital Expenditures | $3.9M | $12.1M | $24.4M | $17.2M | $11.7M | |
| Cash Acquisitions | $26.9M | $37.6M | -- | -- | -- | |
| Cash From Investing | -$39.3M | $93M | $11.5M | -$17.2M | -$11.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$60M | -$389K | -$75K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$19.3M | -$89K | -$1.4M | -- | |
| Cash From Financing | $5.6M | -$79.3M | $79K | -$1.4M | -$451K | |
| Beginning Cash (CF) | $51.1M | $100M | $205.8M | $140.2M | $145.3M | |
| Foreign Exchange Rate Adjustment | -$4.2M | -$2.1M | -$7K | -$1.9M | -$867K | |
| Additions / Reductions | -$20.2M | -$7.1M | $26.9M | $19.8M | $6.5M | |
| Ending Cash (CF) | $26.7M | $90.8M | $232.7M | $158.1M | $150.9M | |
| Levered Free Cash Flow | $13.9M | -$30.8M | -$9.1M | $23.1M | $7.8M | |
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $57M | -$16.2M | $11.8M | -$476.3M | -$602.7M | |
| Depreciation & Amoritzation | $23M | $44.7M | $114.1M | $122.9M | $123.8M | |
| Stock-Based Compensation | $6.7M | $8.2M | $11.8M | $16.4M | $17.8M | |
| Change in Accounts Receivable | -$10.8M | -$50.8M | -$5.8M | -$18.4M | $17.7M | |
| Change in Inventories | -$8.5M | -$7.7M | -$22.5M | -$47.4M | $18M | |
| Cash From Operations | $74.6M | -$5.9M | $112.2M | $18.7M | $64.2M | |
| Capital Expenditures | $20.9M | $44.3M | $95.7M | $112M | $84.7M | |
| Cash Acquisitions | $75.3M | $50.8M | -$50.6M | -- | -- | |
| Cash From Investing | -$157.4M | $142.2M | $29.3M | -$83M | $37.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$40.4M | -$204K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $27.5M | -$78.2M | -$38.6M | $885K | -$99M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$62.7M | $48.9M | $105.8M | -$65.5M | $5.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $53.8M | -$50.2M | $16.5M | -$93.2M | -$20.5M | |
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $27.9M | -$36.6M | -$2M | -$468.9M | $20.4M | |
| Depreciation & Amoritzation | $11.5M | $32.5M | $58.2M | $59.8M | $58M | |
| Stock-Based Compensation | $3.4M | $4.5M | $6.2M | $8.8M | $9.3M | |
| Change in Accounts Receivable | -$1.5M | -$44.5M | $3.6M | $5.3M | $11.3M | |
| Change in Inventories | -$6.9M | $6.5M | -$25.9M | -$17.4M | $16.7M | |
| Cash From Operations | $41.1M | -$32.9M | $38.3M | $22.3M | $30.3M | |
| Capital Expenditures | $5.2M | $25.1M | $55M | $55.6M | $35.7M | |
| Cash Acquisitions | $26.9M | $38.9M | -- | -- | -- | |
| Cash From Investing | -$64.7M | $174.6M | $2.9M | -$50.8M | $86.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$60M | -$389K | -$173K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$19.3M | -$89K | -$1.4M | -- | |
| Cash From Financing | $6.6M | -$78.4M | $1.1M | -$430K | -$99.8M | |
| Beginning Cash (CF) | $122.4M | $207.1M | $384.6M | $260.7M | $284.2M | |
| Foreign Exchange Rate Adjustment | -$7.4M | -$7.9M | $198K | -$1.5M | -$173K | |
| Additions / Reductions | -$24.5M | $55.5M | $42.5M | -$30.4M | $16.3M | |
| Ending Cash (CF) | $90.5M | $254.7M | $427.3M | $228.9M | $300.4M | |
| Levered Free Cash Flow | $35.8M | -$58M | -$16.7M | -$33.3M | -$5.4M | |
Related Companies
Get NEOG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NEOG
Sector
P/E ratio
2,124.15x
23.89x
PEG ratio
-0.13x
-0.01x
P/B ratio
0.96x
1.81x
Price / LTM sales
2.28x
1.59x
Growth Metrics
NEOG
Sector
Revenue growth
-2.84%
4.35%
Earnings growth
96.52%
9.8%
Revenue (5-year growth)
16.43%
6.41%
Earnings forecast
$0.07
-$0.18
Profitability
NEOG
Sector
Profitability FY 2025
$421.4M
$3.2M
Return on invested capital
-18.95%
-32.76%
Return on assets
-16.46%
-29.32%
Return on equity
-25.93%
-38.6%
Earnings Date
Last Earnings Date
Jan
8
Next Earnings Date
Apr
8
Estimated Next Earnings Date
Apr
9
Balance Sheet
NEOG
Sector
Total cash
$145.3M
$25.4M
Short term investments
--
$25.1M
Total assets
$3.5B
$74.7M
Long term debt
$792.9M
$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
75
AGX alert for Jan 17
Argan, Inc. [AGX] is up 16.4% over the past day.
Buy
80
ASTS alert for Jan 17
AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.
Buy
84
IREN alert for Jan 17
IREN Ltd. [IREN] is up 11.35% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
